25 XP   0   0   10

Oneness Biotech Co Ltd
Buy, Hold or Sell?

Let's analyse Oneness Biotech Co Ltd together

PenkeI guess you are interested in Oneness Biotech Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Oneness Biotech Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Oneness Biotech Co Ltd

I send you an email if I find something interesting about Oneness Biotech Co Ltd.

Quick analysis of Oneness Biotech Co Ltd (30 sec.)










What can you expect buying and holding a share of Oneness Biotech Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
NT$32.81
Expected worth in 1 year
NT$39.78
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
NT$6.97
Return On Investment
4.6%

For what price can you sell your share?

Current Price per Share
NT$153.00
Expected price per share
NT$136.61 - NT$170.00
How sure are you?
50%

1. Valuation of Oneness Biotech Co Ltd (5 min.)




Live pricePrice per Share (EOD)

NT$153.00

Intrinsic Value Per Share

NT$-26.60 - NT$-16.45

Total Value Per Share

NT$6.20 - NT$16.36

2. Growth of Oneness Biotech Co Ltd (5 min.)




Is Oneness Biotech Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$456.8m$432.5m$24.2m5.3%

How much money is Oneness Biotech Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$11m-$12.3m$23.4m212.0%
Net Profit Margin33.8%-613.2%--

How much money comes from the company's main activities?

3. Financial Health of Oneness Biotech Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#124 / 1010

Most Revenue
#187 / 1010

Most Profit
#93 / 1010

Most Efficient
#43 / 1010

What can you expect buying and holding a share of Oneness Biotech Co Ltd? (5 min.)

Welcome investor! Oneness Biotech Co Ltd's management wants to use your money to grow the business. In return you get a share of Oneness Biotech Co Ltd.

What can you expect buying and holding a share of Oneness Biotech Co Ltd?

First you should know what it really means to hold a share of Oneness Biotech Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Oneness Biotech Co Ltd is NT$153.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oneness Biotech Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oneness Biotech Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$32.81. Based on the TTM, the Book Value Change Per Share is NT$1.74 per quarter. Based on the YOY, the Book Value Change Per Share is NT$0.73 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oneness Biotech Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.020.0%0.020.0%-0.030.0%-0.010.0%-0.010.0%
Usd Book Value Change Per Share0.050.0%0.050.0%0.020.0%0.170.1%0.130.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.050.0%0.050.0%0.020.0%0.170.1%0.130.1%
Usd Price Per Share7.54-7.54-8.83-5.09-3.54-
Price to Earnings Ratio309.33-309.33--323.33--111.53--237.31-
Price-to-Total Gains Ratio140.83-140.83-395.46-103.67-18.27-
Price to Book Ratio7.48-7.48-9.26-6.44-6.06-
Price-to-Total Gains Ratio140.83-140.83-395.46-103.67-18.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.6971
Number of shares212
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.17
Usd Total Gains Per Share0.050.17
Gains per Quarter (212 shares)11.3535.54
Gains per Year (212 shares)45.38142.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1045350142132
2091800284274
301361250427416
401821700569558
502272150711700
602722600853842
703183050995984
80363350011371126
90408395012801268
100454440014221410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%1.07.00.012.5%1.07.00.012.5%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%5.03.00.062.5%5.03.00.062.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%1.00.07.012.5%1.00.07.012.5%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%5.03.00.062.5%5.03.00.062.5%

Fundamentals of Oneness Biotech Co Ltd

About Oneness Biotech Co Ltd

Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB825, which is in Phase IIa clinical trial for treating atopic dermatitis and allergic asthma; FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis; OB318, an anticancer botanical drug of antrodia cinnamomea; SNS812, for the treatment of COVID-19 that is in Phase I clinical trials; and FB918 for the treatment of asthma. In addition, the company engages in the management of agriculture cultivation and trading business; and production and sale of agricultural products. Oneness Biotech Co., Ltd. was incorporated in 2008 and is headquartered in Taipei, Taiwan.

Fundamental data was last updated by Penke on 2024-04-16 22:41:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Oneness Biotech Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Oneness Biotech Co Ltd earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Oneness Biotech Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 33.8% means that NT$0.34 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oneness Biotech Co Ltd:

  • The MRQ is 33.8%. The company is making a huge profit. +2
  • The TTM is 33.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ33.8%TTM33.8%0.0%
TTM33.8%YOY-613.2%+647.0%
TTM33.8%5Y-960.1%+993.9%
5Y-960.1%10Y-1,530.7%+570.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ33.8%-207.2%+241.0%
TTM33.8%-216.8%+250.6%
YOY-613.2%-282.3%-330.9%
5Y-960.1%-436.8%-523.3%
10Y-1,530.7%-597.3%-933.4%
1.1.2. Return on Assets

Shows how efficient Oneness Biotech Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Oneness Biotech Co Ltd to the Biotechnology industry mean.
  • 2.3% Return on Assets means that Oneness Biotech Co Ltd generated NT$0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oneness Biotech Co Ltd:

  • The MRQ is 2.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.3%TTM2.3%0.0%
TTM2.3%YOY-2.6%+4.9%
TTM2.3%5Y-3.3%+5.6%
5Y-3.3%10Y-3.3%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%-13.3%+15.6%
TTM2.3%-12.8%+15.1%
YOY-2.6%-11.6%+9.0%
5Y-3.3%-13.8%+10.5%
10Y-3.3%-15.6%+12.3%
1.1.3. Return on Equity

Shows how efficient Oneness Biotech Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Oneness Biotech Co Ltd to the Biotechnology industry mean.
  • 2.5% Return on Equity means Oneness Biotech Co Ltd generated NT$0.02 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oneness Biotech Co Ltd:

  • The MRQ is 2.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.5%TTM2.5%0.0%
TTM2.5%YOY-2.9%+5.3%
TTM2.5%5Y-3.8%+6.2%
5Y-3.8%10Y-3.7%-0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5%-16.9%+19.4%
TTM2.5%-16.1%+18.6%
YOY-2.9%-14.9%+12.0%
5Y-3.8%-19.3%+15.5%
10Y-3.7%-20.1%+16.4%

1.2. Operating Efficiency of Oneness Biotech Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Oneness Biotech Co Ltd is operating .

  • Measures how much profit Oneness Biotech Co Ltd makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Oneness Biotech Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of -22.7% means the company generated NT$-0.23  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oneness Biotech Co Ltd:

  • The MRQ is -22.7%. The company is operating very inefficient. -2
  • The TTM is -22.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-22.7%TTM-22.7%0.0%
TTM-22.7%YOY-1,335.3%+1,312.6%
TTM-22.7%5Y-1,198.1%+1,175.4%
5Y-1,198.1%10Y-1,597.2%+399.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.7%-298.0%+275.3%
TTM-22.7%-238.5%+215.8%
YOY-1,335.3%-288.4%-1,046.9%
5Y-1,198.1%-486.2%-711.9%
10Y-1,597.2%-628.4%-968.8%
1.2.2. Operating Ratio

Measures how efficient Oneness Biotech Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.43 means that the operating costs are NT$1.43 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Oneness Biotech Co Ltd:

  • The MRQ is 1.434. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.434. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.434TTM1.4340.000
TTM1.434YOY14.668-13.234
TTM1.4345Y13.498-12.064
5Y13.49810Y19.761-6.263
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4343.235-1.801
TTM1.4343.310-1.876
YOY14.6683.838+10.830
5Y13.4985.679+7.819
10Y19.7617.823+11.938

1.3. Liquidity of Oneness Biotech Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Oneness Biotech Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 39.47 means the company has NT$39.47 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Oneness Biotech Co Ltd:

  • The MRQ is 39.468. The company is very able to pay all its short-term debts. +2
  • The TTM is 39.468. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ39.468TTM39.4680.000
TTM39.468YOY51.206-11.737
TTM39.4685Y40.831-1.363
5Y40.83110Y46.818-5.987
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ39.4683.863+35.605
TTM39.4684.169+35.299
YOY51.2065.337+45.869
5Y40.8316.122+34.709
10Y46.8186.434+40.384
1.3.2. Quick Ratio

Measures if Oneness Biotech Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Oneness Biotech Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 11.53 means the company can pay off NT$11.53 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oneness Biotech Co Ltd:

  • The MRQ is 11.526. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.526. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.526TTM11.5260.000
TTM11.526YOY47.617-36.091
TTM11.5265Y31.173-19.647
5Y31.17310Y34.438-3.264
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.5263.504+8.022
TTM11.5263.991+7.535
YOY47.6175.371+42.246
5Y31.1736.088+25.085
10Y34.4386.395+28.043

1.4. Solvency of Oneness Biotech Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Oneness Biotech Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Oneness Biotech Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.04 means that Oneness Biotech Co Ltd assets are financed with 4.5% credit (debt) and the remaining percentage (100% - 4.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Oneness Biotech Co Ltd:

  • The MRQ is 0.045. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.045. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.045TTM0.0450.000
TTM0.045YOY0.104-0.059
TTM0.0455Y0.080-0.035
5Y0.08010Y0.055+0.025
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0450.339-0.294
TTM0.0450.337-0.292
YOY0.1040.271-0.167
5Y0.0800.368-0.288
10Y0.0550.388-0.333
1.4.2. Debt to Equity Ratio

Measures if Oneness Biotech Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Oneness Biotech Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 4.8% means that company has NT$0.05 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oneness Biotech Co Ltd:

  • The MRQ is 0.048. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.048. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.048TTM0.0480.000
TTM0.048YOY0.117-0.069
TTM0.0485Y0.090-0.042
5Y0.09010Y0.061+0.029
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0480.392-0.344
TTM0.0480.403-0.355
YOY0.1170.335-0.218
5Y0.0900.427-0.337
10Y0.0610.461-0.400

2. Market Valuation of Oneness Biotech Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Oneness Biotech Co Ltd generates.

  • Above 15 is considered overpriced but always compare Oneness Biotech Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 309.33 means the investor is paying NT$309.33 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oneness Biotech Co Ltd:

  • The EOD is 192.778. Based on the earnings, the company is expensive. -2
  • The MRQ is 309.326. Based on the earnings, the company is expensive. -2
  • The TTM is 309.326. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD192.778MRQ309.326-116.549
MRQ309.326TTM309.3260.000
TTM309.326YOY-323.329+632.655
TTM309.3265Y-111.528+420.854
5Y-111.52810Y-237.310+125.782
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD192.778-2.300+195.078
MRQ309.326-2.656+311.982
TTM309.326-2.718+312.044
YOY-323.329-4.145-319.184
5Y-111.528-6.258-105.270
10Y-237.310-6.315-230.995
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oneness Biotech Co Ltd:

  • The EOD is -71.528. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -114.772. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -114.772. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-71.528MRQ-114.772+43.244
MRQ-114.772TTM-114.7720.000
TTM-114.772YOY-335.055+220.283
TTM-114.7725Y4,378.789-4,493.561
5Y4,378.78910Y2,715.908+1,662.882
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-71.528-2.974-68.554
MRQ-114.772-3.306-111.466
TTM-114.772-3.508-111.264
YOY-335.055-5.613-329.442
5Y4,378.789-8.378+4,387.167
10Y2,715.908-8.873+2,724.781
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Oneness Biotech Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.48 means the investor is paying NT$7.48 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Oneness Biotech Co Ltd:

  • The EOD is 4.664. Based on the equity, the company is fair priced.
  • The MRQ is 7.483. Based on the equity, the company is overpriced. -1
  • The TTM is 7.483. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.664MRQ7.483-2.820
MRQ7.483TTM7.4830.000
TTM7.483YOY9.255-1.772
TTM7.4835Y6.445+1.038
5Y6.44510Y6.060+0.385
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.6641.914+2.750
MRQ7.4832.116+5.367
TTM7.4832.097+5.386
YOY9.2552.881+6.374
5Y6.4453.550+2.895
10Y6.0603.936+2.124
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Oneness Biotech Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.7431.7430%0.727+140%5.461-68%4.101-57%
Book Value Per Share--32.80732.8070%31.064+6%22.644+45%16.298+101%
Current Ratio--39.46839.4680%51.206-23%40.831-3%46.818-16%
Debt To Asset Ratio--0.0450.0450%0.104-57%0.080-44%0.055-18%
Debt To Equity Ratio--0.0480.0480%0.117-59%0.090-47%0.061-22%
Dividend Per Share----0%-0%-0%0.005-100%
Eps--0.7940.7940%-0.889+212%-0.372+147%-0.305+138%
Free Cash Flow Per Share---2.139-2.1390%-0.858-60%-0.788-63%-0.752-65%
Free Cash Flow To Equity Per Share---1.143-1.1430%-0.098-91%2.018-157%1.321-186%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---16.446--------
Intrinsic Value_10Y_min---26.604--------
Intrinsic Value_1Y_max---0.976--------
Intrinsic Value_1Y_min---1.431--------
Intrinsic Value_3Y_max---3.444--------
Intrinsic Value_3Y_min---5.395--------
Intrinsic Value_5Y_max---6.530--------
Intrinsic Value_5Y_min---10.528--------
Market Cap69395140224.000-60%111349718464.000111349718464.0000%130399364800.000-15%75250638657.280+48%52341171123.200+113%
Net Profit Margin--0.3380.3380%-6.132+1915%-9.601+2942%-15.307+4631%
Operating Margin---0.227-0.2270%-13.353+5793%-11.981+5187%-15.972+6949%
Operating Ratio--1.4341.4340%14.668-90%13.498-89%19.761-93%
Pb Ratio4.664-60%7.4837.4830%9.255-19%6.445+16%6.060+23%
Pe Ratio192.778-60%309.326309.3260%-323.329+205%-111.528+136%-237.310+177%
Price Per Share153.000-60%245.500245.5000%287.500-15%165.910+48%115.400+113%
Price To Free Cash Flow Ratio-71.528+38%-114.772-114.7720%-335.055+192%4378.789-103%2715.908-104%
Price To Total Gains Ratio87.766-60%140.828140.8280%395.464-64%103.667+36%18.275+671%
Quick Ratio--11.52611.5260%47.617-76%31.173-63%34.438-67%
Return On Assets--0.0230.0230%-0.026+211%-0.033+243%-0.033+244%
Return On Equity--0.0250.0250%-0.029+217%-0.038+253%-0.037+249%
Total Gains Per Share--1.7431.7430%0.727+140%5.461-68%4.106-58%
Usd Book Value--456816122.800456816122.8000%432542246.800+6%315309783.900+45%226942646.788+101%
Usd Book Value Change Per Share--0.0540.0540%0.022+140%0.168-68%0.126-57%
Usd Book Value Per Share--1.0071.0070%0.954+6%0.695+45%0.500+101%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps--0.0240.0240%-0.027+212%-0.011+147%-0.009+138%
Usd Free Cash Flow---29784710.200-29784710.2000%-11948071.600-60%-10974660.560-63%-10469816.713-65%
Usd Free Cash Flow Per Share---0.066-0.0660%-0.026-60%-0.024-63%-0.023-65%
Usd Free Cash Flow To Equity Per Share---0.035-0.0350%-0.003-91%0.062-157%0.041-186%
Usd Market Cap2130430804.877-60%3418436356.8453418436356.8450%4003260499.360-15%2310194606.779+48%1606873953.482+113%
Usd Price Per Share4.697-60%7.5377.5370%8.826-15%5.093+48%3.543+113%
Usd Profit--11051232.50011051232.5000%-12381402.100+212%-5175221.800+147%-4242701.625+138%
Usd Revenue--32712507.80032712507.8000%2018985.500+1520%7400265.700+342%4687068.775+598%
Usd Total Gains Per Share--0.0540.0540%0.022+140%0.168-68%0.126-58%
 EOD+3 -5MRQTTM+0 -0YOY+20 -135Y+19 -1410Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Oneness Biotech Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15192.778
Price to Book Ratio (EOD)Between0-14.664
Net Profit Margin (MRQ)Greater than00.338
Operating Margin (MRQ)Greater than0-0.227
Quick Ratio (MRQ)Greater than111.526
Current Ratio (MRQ)Greater than139.468
Debt to Asset Ratio (MRQ)Less than10.045
Debt to Equity Ratio (MRQ)Less than10.048
Return on Equity (MRQ)Greater than0.150.025
Return on Assets (MRQ)Greater than0.050.023
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Oneness Biotech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.670
Ma 20Greater thanMa 50164.175
Ma 50Greater thanMa 100169.270
Ma 100Greater thanMa 200178.830
OpenGreater thanClose153.500
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Retained Earnings  -254,379-167,817-422,196-211,371-633,567-402,579-1,036,1461,396,121359,975
Income before Tax  -244,941-81,320-326,26176,321-249,940-146,022-395,962847,591451,629
Net Income  -235,436-86,770-322,20680,306-241,900-161,403-403,303763,278359,975
EBITDA  -233,291-20,570-253,861201,712-52,149-141,571-193,7201,144,580950,860
Net Income from Continuing Operations  -244,941-81,320-326,26174,582-251,679-161,144-412,823764,720351,897
Net Income Applicable to Common Shares  -235,436-86,770-322,20680,306-241,900-161,403-403,303763,278359,975



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets15,580,385
Total Liabilities700,381
Total Stockholder Equity14,617,721
 As reported
Total Liabilities 700,381
Total Stockholder Equity+ 14,617,721
Total Assets = 15,580,385

Assets

Total Assets15,580,385
Total Current Assets8,233,280
Long-term Assets7,347,105
Total Current Assets
Cash And Cash Equivalents 5,655,185
Short-term Investments 2,391,554
Net Receivables 12,830
Inventory 111,398
Other Current Assets 42,198
Total Current Assets  (as reported)8,233,280
Total Current Assets  (calculated)8,213,165
+/- 20,115
Long-term Assets
Property Plant Equipment 1,032,938
Goodwill 89,138
Intangible Assets 2,010,070
Other Assets 295,107
Long-term Assets  (as reported)7,347,105
Long-term Assets  (calculated)3,427,253
+/- 3,919,852

Liabilities & Shareholders' Equity

Total Current Liabilities208,604
Long-term Liabilities491,777
Total Stockholder Equity14,617,721
Total Current Liabilities
Short Long Term Debt 110
Accounts payable 1,522
Other Current Liabilities 38,449
Total Current Liabilities  (as reported)208,604
Total Current Liabilities  (calculated)40,081
+/- 168,523
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt263,337
Other Liabilities 241,686
Long-term Liabilities  (as reported)491,777
Long-term Liabilities  (calculated)505,023
+/- 13,246
Total Stockholder Equity
Common Stock3,909,731
Retained Earnings 359,975
Other Stockholders Equity 1,736,716
Total Stockholder Equity (as reported)14,617,721
Total Stockholder Equity (calculated)6,006,422
+/- 8,611,299
Other
Capital Stock3,909,731
Common Stock Shares Outstanding 390,108
Net Invested Capital 14,617,831
Net Tangible Assets 12,518,513
Net Working Capital 8,024,676
Property Plant and Equipment Gross 1,032,938



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
2,807,303
2,555,655
2,521,393
2,335,421
6,979,654
15,384,205
15,731,044
15,580,385
15,580,38515,731,04415,384,2056,979,6542,335,4212,521,3932,555,6552,807,303
   > Total Current Assets 
1,848,132
1,569,249
1,237,325
745,176
1,688,503
8,937,210
8,051,353
8,233,280
8,233,2808,051,3538,937,2101,688,503745,1761,237,3251,569,2491,848,132
       Cash And Cash Equivalents 
694,940
194,326
244,133
150,667
166,559
217,643
332,958
5,655,185
5,655,185332,958217,643166,559150,667244,133194,326694,940
       Short-term Investments 
1,092,533
1,308,947
899,355
478,249
1,421,574
8,099,255
7,472,979
2,391,554
2,391,5547,472,9798,099,2551,421,574478,249899,3551,308,9471,092,533
       Net Receivables 
4,204
2,376
843
15,997
17,199
443,873
14,073
12,830
12,83014,073443,87317,19915,9978432,3764,204
       Inventory 
32,187
41,160
40,723
50,376
48,349
50,187
81,316
111,398
111,39881,31650,18748,34950,37640,72341,16032,187
       Other Current Assets 
24,268
22,440
52,271
49,887
34,822
55,308
35,307
42,198
42,19835,30755,30834,82249,88752,27122,44024,268
   > Long-term Assets 
0
986,406
1,284,068
1,590,245
5,291,151
6,446,995
7,679,691
7,347,105
7,347,1057,679,6916,446,9955,291,1511,590,2451,284,068986,4060
       Property Plant Equipment 
23,526
174,737
455,714
561,012
991,687
1,046,473
1,038,174
1,032,938
1,032,9381,038,1741,046,473991,687561,012455,714174,73723,526
       Goodwill 
0
0
0
0
89,138
89,138
89,138
89,138
89,13889,13889,13889,1380000
       Long Term Investments 
689,913
585,903
552,276
698,397
1,425,932
0
0
0
0001,425,932698,397552,276585,903689,913
       Intangible Assets 
21,617
22,965
23,106
51,925
2,462,470
2,473,584
2,388,327
2,010,070
2,010,0702,388,3272,473,5842,462,47051,92523,10622,96521,617
       Long-term Assets Other 
0
56,083
97,999
128,395
122,152
20,849
30,650
28,203
28,20330,65020,849122,152128,39597,99956,0830
> Total Liabilities 
41,716
31,407
26,464
169,643
520,961
1,624,619
1,641,720
700,381
700,3811,641,7201,624,619520,961169,64326,46431,40741,716
   > Total Current Liabilities 
25,368
31,167
26,224
23,412
71,843
153,693
157,235
208,604
208,604157,235153,69371,84323,41226,22431,16725,368
       Short-term Debt 
0
20
25
81
300
0
0
0
0003008125200
       Short Long Term Debt 
0
20
25
81
300
0
757
110
11075703008125200
       Accounts payable 
254
207
96
528
608
48,428
2,501
1,522
1,5222,50148,42860852896207254
       Other Current Liabilities 
10,320
12,573
6,554
5,310
10,007
23,436
63,850
38,449
38,44963,85023,43610,0075,3106,55412,57310,320
   > Long-term Liabilities 
0
240
240
146,231
449,118
1,470,926
1,484,485
491,777
491,7771,484,4851,470,926449,118146,2312402400
       Capital Lease Obligations Min Short Term Debt
0
-20
-25
-81
328,009
303,089
283,068
263,337
263,337283,068303,089328,009-81-25-200
       Long-term Liabilities Other 
0
240
240
240
480
480
480
480
4804804804802402402400
> Total Stockholder Equity
2,765,587
2,524,248
2,348,612
2,029,924
6,326,608
13,633,202
14,016,375
14,617,721
14,617,72114,016,37513,633,2026,326,6082,029,9242,348,6122,524,2482,765,587
   Common Stock
1,945,422
1,951,722
1,957,522
1,957,522
3,524,908
3,770,857
3,853,175
3,909,731
3,909,7313,853,1753,770,8573,524,9081,957,5221,957,5221,951,7221,945,422
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
54,657
-184,630
-218,046
-472,514
-445,881
1,415,105
1,777,845
1,736,716
1,736,7161,777,8451,415,105-445,881-472,514-218,046-184,63054,657



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue75,885
Cost of Revenue-48,414
Gross Profit27,47127,471
 
Operating Income (+$)
Gross Profit27,471
Operating Expense-1,165,990
Operating Income-1,090,105-1,138,519
 
Operating Expense (+$)
Research Development951,830
Selling General Administrative165,746
Selling And Marketing Expenses-
Operating Expense1,165,9901,117,576
 
Net Interest Income (+$)
Interest Income234,816
Interest Expense-4,504
Other Finance Cost-0
Net Interest Income230,312
 
Pretax Income (+$)
Operating Income-1,090,105
Net Interest Income230,312
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,468,710-1,090,105
EBIT - interestExpense = -4,504
-1,469,246
-1,464,742
Interest Expense4,504
Earnings Before Interest and Taxes (EBIT)--1,464,206
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,468,710
Tax Provision-5,257
Net Income From Continuing Ops-1,473,967-1,473,967
Net Income-1,469,246
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--230,312
 

Technical Analysis of Oneness Biotech Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oneness Biotech Co Ltd. The general trend of Oneness Biotech Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oneness Biotech Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oneness Biotech Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 161.00 < 164.00 < 170.00.

The bearish price targets are: 136.61.

Tweet this
Oneness Biotech Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oneness Biotech Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oneness Biotech Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oneness Biotech Co Ltd. The current macd is -5.5734581.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oneness Biotech Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Oneness Biotech Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Oneness Biotech Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Oneness Biotech Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartOneness Biotech Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oneness Biotech Co Ltd. The current adx is 29.97.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Oneness Biotech Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Oneness Biotech Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oneness Biotech Co Ltd. The current sar is 163.66.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Oneness Biotech Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oneness Biotech Co Ltd. The current rsi is 35.67. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Oneness Biotech Co Ltd Daily Relative Strength Index (RSI) ChartOneness Biotech Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oneness Biotech Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Oneness Biotech Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Oneness Biotech Co Ltd Daily Stochastic Oscillator ChartOneness Biotech Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oneness Biotech Co Ltd. The current cci is -81.79489444.

Oneness Biotech Co Ltd Daily Commodity Channel Index (CCI) ChartOneness Biotech Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oneness Biotech Co Ltd. The current cmo is -29.75924491.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Oneness Biotech Co Ltd Daily Chande Momentum Oscillator (CMO) ChartOneness Biotech Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oneness Biotech Co Ltd. The current willr is -73.13432836.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Oneness Biotech Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Oneness Biotech Co Ltd Daily Williams %R ChartOneness Biotech Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Oneness Biotech Co Ltd.

Oneness Biotech Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oneness Biotech Co Ltd. The current atr is 5.45674826.

Oneness Biotech Co Ltd Daily Average True Range (ATR) ChartOneness Biotech Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oneness Biotech Co Ltd. The current obv is -144,507,331.

Oneness Biotech Co Ltd Daily On-Balance Volume (OBV) ChartOneness Biotech Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oneness Biotech Co Ltd. The current mfi is 22.06.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Oneness Biotech Co Ltd Daily Money Flow Index (MFI) ChartOneness Biotech Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oneness Biotech Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Oneness Biotech Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oneness Biotech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.670
Ma 20Greater thanMa 50164.175
Ma 50Greater thanMa 100169.270
Ma 100Greater thanMa 200178.830
OpenGreater thanClose153.500
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Oneness Biotech Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Oneness Biotech Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oneness Biotech Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oneness Biotech Co Ltd

I send you an email if I find something interesting about Oneness Biotech Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Oneness Biotech Co Ltd.

Receive notifications about Oneness Biotech Co Ltd in your mailbox!